Bayer, J&J Settle U.S. Xarelto Litigation For $775 million

Credit: Wochit News
Published on March 25, 2019 - Duration: 00:53s

Bayer, J&J Settle U.S. Xarelto Litigation For $775 million

Bayer AG and Johnson & Johnson have agreed to settle more than 25,000 U.S. lawsuits over blood thinner Xarelto for a total of $775 million.

According to Reuters, the amount will be shared equally between the two companies that jointly developed the drug.

The settlement will resolve all pending U.S. lawsuits over Xarelto.

Plaintiffs claimed causes uncontrollable and irreversible bleeding leading to severe injuries and even death among thousands of plaintiffs.

Advertisement

Bayer, J&J Settle U.S. Xarelto Litigation For $775 million

OCT 16 2012 PHOTO MAY 25, 2018 FILE PHOTO JULY 30 2013 FILE PHOTO MONDAY, MAY 23, 2016, FILE PHOTO TUESDAY, JULY 30, 2013, FILE PHOTO AP PROVIDES ACCESS TO THIS THIRD PARTY PHOTO SOLELY TO ILLUSTRATE NEWS REPORTING OR COMMENTARY ON FACTS DEPICTED IN IMAGE; MUST BE USED WITHIN 14 DAYS FROM TRANSMISSION; NO ARCHIVING; NO LICENSING; MANDATORY CREDIT

You are here

You might like